MariMed Inc (MRMD)
0.2672
+0.01
(+3.37%)
USD |
OTCM |
Apr 25, 16:00
MariMed Gross Profit Margin (Quarterly): 44.52% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.52% |
| September 30, 2023 | 43.40% |
| June 30, 2023 | 44.84% |
| March 31, 2023 | 44.76% |
| December 31, 2022 | 44.13% |
| September 30, 2022 | 47.66% |
| June 30, 2022 | 45.49% |
| March 31, 2022 | 54.27% |
| December 31, 2021 | 49.90% |
| September 30, 2021 | 54.75% |
| June 30, 2021 | 59.58% |
| March 31, 2021 | 53.51% |
| December 31, 2020 | 57.07% |
| September 30, 2020 | 64.48% |
| June 30, 2020 | 64.08% |
| March 31, 2020 | 65.20% |
| December 31, 2019 | 54.18% |
| September 30, 2019 | 41.88% |
| June 30, 2019 | 34.77% |
| March 31, 2019 | 64.31% |
| December 31, 2018 | 79.15% |
| September 30, 2018 | 55.13% |
| June 30, 2018 | 68.91% |
| March 31, 2018 | 57.33% |
| December 31, 2017 | 20.20% |
| Date | Value |
|---|---|
| September 30, 2017 | 73.89% |
| June 30, 2017 | 76.82% |
| March 31, 2017 | 65.13% |
| December 31, 2016 | 72.13% |
| September 30, 2016 | 51.61% |
| June 30, 2016 | 66.85% |
| March 31, 2016 | 48.54% |
| December 31, 2015 | -44.35% |
| September 30, 2015 | 71.16% |
| June 30, 2015 | 39.44% |
| March 31, 2015 | -12.79% |
| December 31, 2014 | -108.5% |
| September 30, 2014 | -930.0% |
| June 30, 2014 | -981.1% |
| March 31, 2014 | -1.03K% |
| December 31, 2013 | -2.25K% |
| September 30, 2013 | -752.3% |
| June 30, 2013 | -10.51K% |
| March 31, 2013 | -2.14K% |
| December 31, 2012 | -3.56K% |
| September 30, 2012 | -2.09K% |
| June 30, 2012 | -2.19K% |
| March 31, 2012 | -2.38K% |
| September 30, 2011 | 58.10% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
34.77%
Minimum
Jun 2019
65.20%
Maximum
Mar 2020
50.97%
Average
49.90%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 31.42% |
| Zymeworks Inc | -- |
| Viemed Healthcare Inc | 63.29% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.69% |
| Return on Assets | -8.78% |
| Return on Invested Capital | -13.22% |
| Profit Margin (Quarterly) | -26.14% |
| Operating Margin (Quarterly) | 6.95% |
| Return on Net Operating Assets | -10.67% |